When Gpx4 was deficient, there was increased lipid peroxidation and impaired antibody responses in B1 and marginal zone B cells (64), which may explain why GPX4-positive patients had poor overall survival than GPX4-negative patients in B-cell lymphoma (65). This evidence concerns the gene GPX4 and B-cell non-Hodgkin lymphoma.